A steady-state modeling approach for simulation of antimicrobial peptide-cell membrane interaction

Biochimica Et Biophysica Acta. Biomembranes
Sumana SrinivasanKareenhalli V Venkatesh

Abstract

Antimicrobial Peptides (AMPs) are host defense molecules that initiate microbial death by binding to the membrane. On membrane binding, AMPs undergo changes in conformation and aggregation state to enable killing action. Depending on the AMP and cell membrane characteristics, the nature of binding can be aggregating or non-aggregating, with high/low cooperativity, at single or multiple sites with high/low affinity leading to a unique killing action that needs to be studied individually. In the present study, a steady-state model that simulates AMP-membrane interaction was developed and was used to predict the mechanism of AMP binding. The predictions obtained from the model were validated with experimentally deciphered values available in literature. The model was further used to predict the mechanism for a set of designed AMPs with high sequence similarity to Myeloid Antimicrobial Peptide (MAP) family. Depending on the predicted mechanism, a unique half saturation constant and steepness of response (Hill coefficient) was obtained which was further validated with available data from literature. The model could reliably predict the mechanism, the half saturation constant and the Hill coefficient values. Further based on the anal...Continue Reading

References

Sep 16, 1998·Antimicrobial Agents and Chemotherapy·J TurnerR I Lehrer
Feb 22, 2002·European Journal of Biochemistry·Brian F TackRobert I Lehrer
Apr 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Domenico RaimondoAndrea Scaloni
Jul 22, 2008·Biophysical Journal·Peter J BondMark S P Sansom
Jul 14, 2009·General Physiology and Biophysics·Karl Lohner
Sep 10, 2010·Biochimica Et Biophysica Acta·Seong-Cheol ParkYoonkyung Park
Apr 21, 2011·Biophysical Journal·Benjamin A HallMark S P Sansom
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·Christopher W KaplanRandal Eckert
Sep 7, 2011·Journal of Molecular Microbiology and Biotechnology·Sylvia A Baltzer, Melissa H Brown
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·E N LorenzónE M Cilli
May 30, 2013·Antimicrobial Agents and Chemotherapy·David PulidoEster Boix
Aug 12, 2014·Biochimica Et Biophysica Acta·Jiarong WangJunfeng Wang
Sep 23, 2014·Trends in Biochemical Sciences·James E Ferrell, Sang Hoon Ha
Oct 16, 2015·Nucleic Acids Research·Faiza Hanif WaghuSusan Idicula-Thomas
Nov 26, 2015·Nucleic Acids Research·Guangshun WangZhe Wang
Apr 15, 2016·Scientific Reports·Linlin FanHanmei Xu
Mar 13, 2018·Frontiers in Microbiology·Faiza H WaghuSusan Idicula-Thomas

❮ Previous
Next ❯

Citations

Mar 13, 2021·Chemical Society Reviews·Wenyi LiJohn D Wade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Antimicrobial Agents and Chemotherapy
Guozhi YuJens Rolff
Journal of Peptide Science : an Official Publication of the European Peptide Society
Milad AbdiNour Amirmozafari
© 2021 Meta ULC. All rights reserved